Epiminder (ASX:EPI) Valuation Rank


ASX:EPI Epiminder Ltd ASX:EPI
17 GF Score
Price A$0.32
View Full Analysis

What is Epiminder Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Epiminder Valuation Rank Related Terms

ASX:EPI
17GF Score
Epiminder Ltd ASX:EPI
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Epiminder Business Description

Address 525 Collins Street, 210 West Podium, Mezzanine 2, Melbourne, VIC, AUS, 3000
Epiminder Ltd is a medical device and information solutions company focused on developing diagnostic and treatment tools for epilepsy. Its system is a sub-scalp device for continuous monitoring of electrographic brain activity and a set of information solutions, providing patients and their healthcare professionals with detailed data over an extended period.
17GF Score

Get the complete analysis for ASX:EPI

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.32
Price